Update:: the twenty subtypes of HLA-B27

被引:46
作者
Khan, MA [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Div Rheumatol, Cleveland, OH USA
关键词
D O I
10.1097/00002281-200007000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HLA-B27 is a serologic specificity that encompasses 20 different alleles-HLA-B*2701 to B*2720. These alleles are also called subtypes of HLA-B27, and they have evolved from the B*2705 subtype, mostly from changes in exons 2 and 3 (which encode the alpha 1 and alpha 2 domains of the peptide binding groove, respectively). Occurrence of ankylosing spondylitis (AS) or related spondyloarthropathy (SpA) has thus far been documented in subjects possessing any one of the first 10 subtypes. However, B*2706 in Southeast Asian and B*2709 in the Italian island population of Sardinia may have a relatively much weaker association with AS. The 10 most recent subtypes have not yet been studied for disease association. There may exist a hierarchical ranking, resulting, in part, from differences in other cc-inherited genetic factors, or due to environmental factors; eg, B*2705 is clearly disease-associated throughout the world, but not among the West Africans of Senegal and Gambia. It is important to investigate whether certain subtypes show any preferential association with some of the clinical features or forms of AS and related SpA among the various ethnic/racial populations and geographic regions of the world. This may help to identify the polymorphic positions of HLA-B27 that may have a disease-predisposing role. (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 39 条
[1]   Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles [J].
Armas, JB ;
Gonzalez, S ;
Martinez-Borra, J ;
Laranjeira, F ;
Ribeiro, E ;
Correia, J ;
Ferreira, ML ;
Toste, M ;
López-Vazquez, A ;
López-Larrea, C .
TISSUE ANTIGENS, 1999, 53 (03) :237-243
[2]  
Balas A, 1998, TISSUE ANTIGENS, V51, P394
[3]   Ankylosing spondylitis in west Africans - Evidence for a non-HLA-B27 protective effect [J].
Brown, MA ;
Jepson, A ;
Young, A ;
Whittle, HC ;
Greenwood, BM ;
Wordsworth, BP .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (01) :68-70
[4]   RELEVANCE OF RESIDUE-116 OF HLA-B27 IN DETERMINING SUSCEPTIBILITY TO ANKYLOSING-SPONDYLITIS [J].
DAMATO, M ;
FIORILLO, MT ;
CARCASSI, C ;
MATHIEU, A ;
ZUCCARELLI, A ;
BITTI, PP ;
TOSI, R ;
SORRENTINO, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3199-3201
[5]  
DELPORTO P, 1994, J IMMUNOL, V153, P3093
[6]   HLA-B*27 subtyping by PCR-RFLP in Spanish patients with ankylosing spondylitis [J].
Fraile, A ;
Martin, J ;
López-Nevot, MA ;
Mataran, L ;
Nieto, A .
TISSUE ANTIGENS, 1998, 52 (05) :492-496
[7]  
García F, 1998, TISSUE ANTIGENS, V51, P1
[8]  
García-Peydró M, 1999, J IMMUNOL, V163, P2299
[9]  
Gonzalez Segundo, 1999, Current Opinion in Rheumatology, V11, P257, DOI 10.1097/00002281-199907000-00006
[10]   HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis [J].
GonzalezRoces, S ;
Alvarez, MV ;
Gonzalez, S ;
Dieye, A ;
Makni, H ;
Woodfield, DG ;
Housan, L ;
Konenkov, V ;
Abbadi, MC ;
Grunnet, N ;
Coto, E ;
LopezLarrea, C .
TISSUE ANTIGENS, 1997, 49 (02) :116-123